Quantamental Technologies LLC Abb Vie Inc. Transaction History

Quantamental Technologies LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $1.37 Million - $1.71 Million	10,352 New	10,352 $1.39 Million
Q3 2019 Nov 08, 2019	SELL	$62.98 - $75.72 $122,559 - $147,351	-1,946 Closed	0 $0
Q2 2019 Aug 12, 2019	SELL	$65.7 - $83.98 $33,966 - $43,417	-517 Reduced 20.99%	1,946 $142,000
Q1 2019 Apr 29, 2019	SELL	$77.14 - $90.79 $4,551 - $5,356	-59 Reduced 2.34%	2,463 $198,000
Q4 2018 Jan 28, 2019	BUY	$77.85 - $96.01 $196,337 - $242,137	2,522 New	2,522 $233,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantamental Technologies LLC with notifications on news.